MusthInsider

Latest On Akero Therapeutics, Inc (AKRO):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-18 02:59 EST	News	Akero Therapeutics: A Promising Solution For NASH Patients And Investors	N/A
2023-05-17 13:48 EST	News	Akero Therapeutics prices $220M offering	N/A
2023-05-15 20:39 EST	News	Akero Therapeutics GAAP EPS of -$0.55	N/A
2023-05-09 09:17 EST	News	Akero Therapeutics: Proof Of Concept With EFX, Sets Up Catalyst Opportunities In 2023	N/A
2023-05-07 19:00 EST	News	Akero Therapeutics: Excellent Data, Solid Clinical Potential, No Major Near Term Catalysts	N/A
2023-03-30 00:33 EST	News	Akero plans to begin Phase 3 trial of NASH treatment in H2 after successful FDA meet	N/A
2023-03-17 20:34 EST	News	Akero Therapeutics GAAP EPS of -$0.49 beats by $0.31	N/A
2023-02-08 18:19 EST	News	Akero Therapeutics: NASH Differentiator Attractive, Awaiting Additional Price Catalysts	N/A
2023-01-27 18:31 EST	News	Akero upgraded at Morgan Stanley on NASH prospects	N/A
2022-12-08 21:25 EST	News	Akero's liver disease drug gets FDA breakthrough therapy tag	N/A
2022-11-24 02:08 EST	News	Akero Therapeutics: What Is Making The Stock Tick	N/A
2022-11-04 15:25 EST	News	Akero Therapeutics GAAP EPS of -$0.92 misses by $0.20	N/A
2022-10-25 22:18 EST	News	Akero: Putting Together The Pieces They Let Us See	N/A
2022-09-19 18:37 EST	News	Akero Therapeutics announces closing of upsized public offering	N/A
2022-09-19 02:04 EST	News	Akero Therapeutics: A Promising NASH Innovator	N/A
2022-09-16 05:21 EST	News	Akero Therapeutics: Outstanding Data In NASH	N/A
2022-09-15 11:26 EST	News	Akero Therapeutics stock slides on pricing upsized ~$200.0M stock offering	N/A
2022-09-14 18:07 EST	News	Akero Therapeutics' Positive NASH Trial Results And Cash Raise	N/A
2022-09-14 00:37 EST	News	Akero stock soars 71% as drug improves liver fibrosis, prevents disease worsening in trial	N/A
2022-09-14 00:36 EST	News	Akero adds over 100% rallying peers after NASH success	N/A
2022-09-14 00:36 EST	News	Akero Therapeutics commences underwritten public offering of $175M of shares	N/A
2022-08-04 23:03 EST	News	Akero Therapeutics GAAP EPS of -$0.77 beats by $0.10	N/A
2022-06-16 14:38 EST	News	Pfizer makes $25M equity investment in Akero	N/A
2022-05-06 18:49 EST	News	Akero Therapeutics GAAP EPS of -$0.74 beats by $0.07	N/A
2022-02-25 22:21 EST	News	Akero Therapeutics GAAP EPS of -$0.93 misses by $0.13	N/A
2022-02-09 07:08 EST	News	Akero finishes enrollment in phase 2b trial of efruxifermin in liver disease	N/A
2022-01-12 18:10 EST	News	Akero Therapeutics (AKRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference	N/A
2022-01-12 18:10 EST	News	Akero Therapeutics (AKRO) Investor Presentation - Slideshow	N/A
2021-11-12 16:26 EST	News	Akero Therapeutics EPS beats by $0.16	N/A
2021-10-20 02:11 EST	News	Akero nabs Fast Track designation for efruxifermin for NASH	N/A
2021-10-12 20:08 EST	News	Warning: AKRO is at high risk of performing badly	N/A
2021-10-07 04:15 EST	News	AKRO is at high risk of performing badly	N/A
2021-09-27 12:22 EST	News	Warning: AKRO has been downgraded to Very Bearish	N/A
2021-09-23 22:19 EST	News	Akero: Ticking All The Right Boxes In NASH	N/A
2021-09-22 20:56 EST	News	Warning: AKRO has been downgraded to Very Bearish.	N/A
2021-09-10 16:11 EST	News	Akero initiated with a buy at BofA on underappreciated clinical profile	N/A
2021-08-13 08:25 EST	News	Akero Therapeutics EPS misses by $0.17	N/A
2021-07-20 18:14 EST	News	Akero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trial	N/A
2021-07-20 18:08 EST	News	Akero Therapeutics adds Judy Chou to its board of directors	N/A
2021-04-21 13:38 EST	News	89bio could close the valuation gap with Akero by end of 2021: Cantor	N/A
2021-03-18 12:04 EST	Analyst Rating	The Analyst Target Price has decreased from $59.5 to $58.75.	Neutral
2021-03-17 20:05 EST	Financials	Company financials have been released.	Neutral
2021-03-17 12:03 EST	Earnings Estimate	An EPS average of -$3.73 is estimated for the 2022 year.	Sell
2021-03-17 12:03 EST	Earnings Estimate	An EPS average of -$0.80 is estimated for the quarter ending on June 30, 2021.	Buy
2021-03-16 18:57 EST	News	Akero Therapeutics EPS misses by $0.29	N/A
2021-03-01 11:04 EST	Analyst Rating	The Analyst Target Price has decreased from $60.29 to $59.5.	Neutral
2020-12-13 03:07 EST	Financials	Company financials have been released.	Neutral
2020-12-11 15:05 EST	Financials	Company financials have been released.	Neutral
2020-11-25 11:09 EST	Financials	Company financials have been released.	Neutral
2020-11-17 03:04 EST	Financials	Company financials have been released.	Neutral

About Akero Therapeutics, Inc (AKRO):

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

See Advanced Chart

General

Name Akero Therapeutics, Inc
Symbol AKRO
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 13
Fiscal Year EndDecember
IPO Date2019-06-20
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Web URLhttp://www.akerotx.com

Valuation

Trailing PE 8.18
Price/Book (Most Recent Quarter) 4.38

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$3.88
Next Year EPS Estimate -$4.26
Next Quarter EPS Estimate -$0.55
Return on Assets -18%
Return on Equity -30%
Earnings Per Share -$91.75
Revenue Per Share $0
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 1.11 billion
Analyst Target Price $58.75
Book Value Per Share $8.25

Share Statistics

Shares Outstanding 34.77 million
Shares Float 17.06 million
% Held by Insiders 840%
% Held by Institutions 93.8%
Shares Short 2.23 million
Shares Short Prior Month 2.13 million
Short Ratio 9.66
Short % of Float 12%
Short % of Shares Outstanding 6%

Technicals

52 Week High $41.16
52 Week Low $15.02
50 Day Moving Average 31.18
200 Day Moving Average 29.64

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Akero Therapeutics, Inc (AKRO) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Akero Therapeutics, Inc (AKRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-16	$N/A	-$0.86	-$0.59	-45.76%
2020-09-30	2020-11-12	$N/A	-$0.63	-$0.67	6.11%
2020-06-30	2020-08-12	$N/A	-$0.57	-$0.62	7.72%
2020-03-31	2020-05-13	$N/A	-$0.42	-$0.61	31.15%
2019-12-31	2020-03-16	$N/A	-$0.55	-$0.58	5.97%
2019-09-30	2019-11-12	$N/A	-$0.56	-$0.43	-30.69%
2019-06-30	2019-08-12	$N/A	-$0.26	-$0.36	28.51%

Akero Therapeutics, Inc (AKRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Akero Therapeutics, Inc (AKRO) Chart:

Akero Therapeutics, Inc (AKRO) News:

Below you will find a list of latest news for Akero Therapeutics, Inc (AKRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akero Therapeutics, Inc (AKRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-04-17	25	0	CALL	0	0	170.21	TRUE	0	0
2025-04-17	27.5	0	CALL	0	0	156.03	TRUE	0	0
2025-04-17	30	0	CALL	0	0	109.78	TRUE	0	0
2025-04-17	32.5	0	CALL	0	0	102.45	TRUE	0	0
2025-04-17	35	10.05	CALL	0	1	75.81	TRUE	0	0
2025-04-17	37.5	0	CALL	0	0	48.31	TRUE	0	0
2025-04-17	40	0	CALL	0	0	51.32	TRUE	0	0
2025-04-17	42.5	1.95	CALL	0	33	48.11	TRUE	0	0
2025-04-17	45	2.9	CALL	0	313	50.98	FALSE	0	0
2025-04-17	47.5	0.61	CALL	2	235	53.75	FALSE	0.61	0
2025-04-17	50	0.29	CALL	44	488	54.41	FALSE	0.29	0
2025-04-17	52.5	0.15	CALL	5	129	56.68	FALSE	0.15	0
2025-04-17	55	0.05	CALL	0	7678	66.39	FALSE	0	0
2025-04-17	57.5	1	CALL	0	12	91.96	FALSE	0	0
2025-04-17	60	0	CALL	0	0	105.94	FALSE	0	0
2025-04-17	65	0	CALL	0	0	118.53	FALSE	0	0
2025-04-17	70	0	CALL	0	0	133.78	FALSE	0	0
2025-04-17	75	0	CALL	0	0	147.55	FALSE	0	0
2025-04-17	25	0	PUT	0	0	160.84	FALSE	0	0
2025-04-17	27.5	0	PUT	0	0	136.93	FALSE	0	0
2025-04-17	30	0	PUT	0	0	114.82	FALSE	0	0
2025-04-17	32.5	0.2	PUT	0	2	78.16	FALSE	0	0
2025-04-17	35	0.5	PUT	0	20	66.42	FALSE	0	0
2025-04-17	37.5	0.24	PUT	1	117	47.95	FALSE	0.24	0
2025-04-17	40	0.65	PUT	0	344	58.49	FALSE	0	0
2025-04-17	42.5	3.15	PUT	0	2528	28.26	FALSE	0	0
2025-04-17	45	1.9	PUT	0	1272	47.75	TRUE	0	0
2025-04-17	47.5	3.7	PUT	0	61	48.02	TRUE	0	0
2025-04-17	50	4.8	PUT	0	18	91.13	TRUE	0	0
2025-04-17	52.5	8.97	PUT	0	5	72.24	TRUE	0	0
2025-04-17	55	0	PUT	0	0	77.47	TRUE	0	0
2025-04-17	57.5	0	PUT	0	0	153.79	TRUE	0	0
2025-04-17	60	0	PUT	0	0	144.83	TRUE	0	0
2025-04-17	65	0	PUT	0	0	169.33	TRUE	0	0
2025-04-17	70	0	PUT	0	0	210.19	TRUE	0	0
2025-04-17	75	0	PUT	0	0	238.09	TRUE	0	0
2025-05-16	12.5	0	CALL	0	0	179.09	TRUE	0	0
2025-05-16	15	0	CALL	0	0	166.72	TRUE	0	0
2025-05-16	17.5	0	CALL	0	0	128.8	TRUE	0	0
2025-05-16	20	0	CALL	0	0	150.41	TRUE	0	0
2025-05-16	22.5	12.33	CALL	0	0	129.66	TRUE	0	0
2025-05-16	25	27.5	CALL	0	4	92.01	TRUE	0	0
2025-05-16	27.5	0	CALL	0	0	101.17	TRUE	0	0
2025-05-16	30	27.15	CALL	0	2	38.77	TRUE	0	0
2025-05-16	32.5	7.99	CALL	0	5	74.95	TRUE	0	0
2025-05-16	35	15.5	CALL	0	27	65.52	TRUE	0	0
2025-05-16	37.5	14.5	CALL	0	4	54.93	TRUE	0	0
2025-05-16	40	7	CALL	0	1806	51.24	TRUE	0	0
2025-05-16	42.5	4.2	CALL	0	41	52.36	TRUE	0	0
2025-05-16	45	2.13	CALL	0	135	51.65	FALSE	0	0
2025-05-16	47.5	2.2	CALL	0	12	52.19	FALSE	0	0
2025-05-16	50	1.85	CALL	0	393	53.86	FALSE	0	0
2025-05-16	52.5	0.8	CALL	50	251	55.6	FALSE	0.8	0
2025-05-16	55	0.5	CALL	20	349	55.05	FALSE	0.5	0
2025-05-16	57.5	0.45	CALL	0	166	49.78	FALSE	0	0
2025-05-16	60	0.85	CALL	0	114	57.85	FALSE	0	0
2025-05-16	62.5	4	CALL	0	1	68.88	FALSE	0	0
2025-05-16	65	1.23	CALL	0	57	74.11	FALSE	0	0
2025-05-16	70	0	CALL	0	0	83.73	FALSE	0	0
2025-05-16	75	0.75	CALL	0	5	92.4	FALSE	0	0
2025-05-16	80	1.65	CALL	0	12	100.31	FALSE	0	0
2025-05-16	85	1.25	CALL	0	1	169.29	FALSE	0	0
2025-05-16	12.5	0.3	PUT	0	7	210.79	FALSE	0	0
2025-05-16	15	1.5	PUT	0	11	181.72	FALSE	0	0
2025-05-16	17.5	2.75	PUT	0	12	157.45	FALSE	0	0
2025-05-16	20	0.1	PUT	0	10	136.58	FALSE	0	0
2025-05-16	22.5	4.8	PUT	0	11	118.19	FALSE	0	0
2025-05-16	25	8.8	PUT	0	4	101.7	FALSE	0	0
2025-05-16	27.5	7.6	PUT	0	9	86.66	FALSE	0	0
2025-05-16	30	0.2	PUT	0	14	72.76	FALSE	0	0
2025-05-16	32.5	1.55	PUT	0	1	59.71	FALSE	0	0
2025-05-16	35	1.06	PUT	0	5	49.06	FALSE	0	0
2025-05-16	37.5	1.7	PUT	0	25	49.97	FALSE	0	0
2025-05-16	40	1.95	PUT	0	623	50.13	FALSE	0	0
2025-05-16	42.5	2.75	PUT	0	114	50.65	FALSE	0	0
2025-05-16	45	3.5	PUT	0	567	49.99	TRUE	0	0
2025-05-16	47.5	6.1	PUT	0	47	52.17	TRUE	0	0
2025-05-16	50	7	PUT	1	316	71.55	TRUE	7	0
2025-05-16	52.5	8.74	PUT	0	13	38.72	TRUE	0	0
2025-05-16	55	11.06	PUT	0	21	63.26	TRUE	0	0
2025-05-16	57.5	7.2	PUT	0	55	56.79	TRUE	0	0
2025-05-16	60	14.95	PUT	0	47	52.75	TRUE	0	0
2025-05-16	62.5	0	PUT	0	0	96.07	TRUE	0	0
2025-05-16	65	0	PUT	0	0	99.77	TRUE	0	0
2025-05-16	70	0	PUT	0	0	121.74	TRUE	0	0
2025-05-16	75	0	PUT	0	0	142.17	TRUE	0	0
2025-05-16	80	0	PUT	0	0	154.59	TRUE	0	0
2025-05-16	85	0	PUT	0	0	173.04	TRUE	0	0
2025-08-15	12.5	0	CALL	0	0	112.98	TRUE	0	0
2025-08-15	15	41.13	CALL	0	3	98.15	TRUE	0	0
2025-08-15	17.5	0	CALL	0	0	77.84	TRUE	0	0
2025-08-15	20	0	CALL	0	0	90.89	TRUE	0	0
2025-08-15	22.5	0	CALL	0	0	87.1	TRUE	0	0
2025-08-15	25	18.4	CALL	1	4	56.56	TRUE	18.4	0
2025-08-15	27.5	16.29	CALL	1	4	59.2	TRUE	16.29	0
2025-08-15	30	25.6	CALL	0	11	61.97	TRUE	0	0
2025-08-15	32.5	0	CALL	0	0	48.1	TRUE	0	0
2025-08-15	35	0	CALL	0	0	49.68	TRUE	0	0
2025-08-15	37.5	7.2	CALL	0	3	50.19	TRUE	0	0
2025-08-15	40	0	CALL	0	0	50.58	TRUE	0	0
2025-08-15	42.5	7.3	CALL	0	29	50.47	TRUE	0	0
2025-08-15	45	4.7	CALL	2	344	51	FALSE	-0.5	-0.1
2025-08-15	47.5	3.9	CALL	2	90	51.83	FALSE	3.9	0
2025-08-15	50	3.2	CALL	4	129	48.01	FALSE	0	0
2025-08-15	52.5	2.5	CALL	0	34	51.35	FALSE	0	0
2025-08-15	55	2	CALL	0	32	50.78	FALSE	0	0
2025-08-15	57.5	2.85	CALL	0	12	54.75	FALSE	0	0
2025-08-15	60	1.8	CALL	0	47	51.47	FALSE	0	0
2025-08-15	62.5	4.1	CALL	0	7	51.31	FALSE	0	0
2025-08-15	65	1.35	CALL	0	18	50.59	FALSE	0	0
2025-08-15	70	1.9	CALL	0	37	49.71	FALSE	0	0
2025-08-15	75	1.35	CALL	0	5	49.5	FALSE	0	0
2025-08-15	80	1	CALL	0	2	58.18	FALSE	0	0
2025-08-15	85	2.75	CALL	0	1	98.55	FALSE	0	0
2025-08-15	12.5	0	PUT	0	0	124.81	FALSE	0	0
2025-08-15	15	0	PUT	0	0	107.71	FALSE	0	0
2025-08-15	17.5	0	PUT	0	0	93.45	FALSE	0	0
2025-08-15	20	0	PUT	0	0	81.17	FALSE	0	0
2025-08-15	22.5	0	PUT	0	0	70.37	FALSE	0	0
2025-08-15	25	0	PUT	0	0	60.68	FALSE	0	0
2025-08-15	27.5	0	PUT	0	0	55	FALSE	0	0
2025-08-15	30	0.76	PUT	0	2	49.6	FALSE	0	0
2025-08-15	32.5	1.4	PUT	0	4	50.13	FALSE	0	0
2025-08-15	35	1.75	PUT	0	9	54.03	FALSE	0	0
2025-08-15	37.5	1.9	PUT	0	43	49.39	FALSE	0	0
2025-08-15	40	3.5	PUT	0	408	50.4	FALSE	0	0
2025-08-15	42.5	4.9	PUT	0	31	59.32	FALSE	0	0
2025-08-15	45	6.1	PUT	0	367	53.62	TRUE	0	0
2025-08-15	47.5	6.9	PUT	0	85	57.5	TRUE	0	0
2025-08-15	50	8.7	PUT	0	31	57.69	TRUE	0	0
2025-08-15	52.5	10.4	PUT	0	42	46.33	TRUE	0	0
2025-08-15	55	10.8	PUT	0	19	47.54	TRUE	0	0
2025-08-15	57.5	11.6	PUT	0	10	41.76	TRUE	0	0
2025-08-15	60	11	PUT	0	17	62.25	TRUE	0	0
2025-08-15	62.5	0	PUT	0	0	46.33	TRUE	0	0
2025-08-15	65	0	PUT	0	0	65.29	TRUE	0	0
2025-08-15	70	0	PUT	0	0	88.41	TRUE	0	0
2025-08-15	75	0	PUT	0	0	55.88	TRUE	0	0
2025-08-15	80	29.1	PUT	0	0	100.79	TRUE	0	0
2025-08-15	85	0	PUT	0	0	108	TRUE	0	0
2025-11-21	22.5	0	CALL	0	0	60.41	TRUE	0	0
2025-11-21	25	0	CALL	0	0	54.29	TRUE	0	0
2025-11-21	27.5	0	CALL	0	0	49.35	TRUE	0	0
2025-11-21	30	0	CALL	0	0	58.16	TRUE	0	0
2025-11-21	32.5	0	CALL	0	0	52.98	TRUE	0	0
2025-11-21	35	0	CALL	0	0	52.95	TRUE	0	0
2025-11-21	37.5	0	CALL	0	0	54.62	TRUE	0	0
2025-11-21	40	0	CALL	0	0	52.85	TRUE	0	0
2025-11-21	42.5	0	CALL	0	0	52.11	TRUE	0	0
2025-11-21	45	0	CALL	0	0	51.54	FALSE	0	0
2025-11-21	47.5	0	CALL	0	0	50.81	FALSE	0	0
2025-11-21	50	0	CALL	0	0	50.34	FALSE	0	0
2025-11-21	52.5	0	CALL	0	0	50.57	FALSE	0	0
2025-11-21	55	3.6	CALL	0	2	50.1	FALSE	0	0
2025-11-21	60	3.3	CALL	0	2	50.65	FALSE	0	0
2025-11-21	65	0	CALL	0	0	51.81	FALSE	0	0
2025-11-21	22.5	0	PUT	0	0	55.42	FALSE	0	0
2025-11-21	25	0	PUT	0	0	47.2	FALSE	0	0
2025-11-21	27.5	0	PUT	0	0	50.89	FALSE	0	0
2025-11-21	30	1.35	PUT	0	2	51.53	FALSE	0	0
2025-11-21	32.5	2	PUT	0	2	50.77	FALSE	0	0
2025-11-21	35	0	PUT	0	0	52.53	FALSE	0	0
2025-11-21	37.5	0	PUT	0	0	49.72	FALSE	0	0
2025-11-21	40	4	PUT	0	1	54.26	FALSE	0	0
2025-11-21	42.5	0	PUT	0	0	54.53	FALSE	0	0
2025-11-21	45	0	PUT	0	0	50.11	TRUE	0	0
2025-11-21	47.5	0	PUT	0	0	49.97	TRUE	0	0
2025-11-21	50	0	PUT	0	0	49.64	TRUE	0	0
2025-11-21	52.5	0	PUT	0	0	50.35	TRUE	0	0
2025-11-21	55	0	PUT	0	0	46.17	TRUE	0	0
2025-11-21	60	0	PUT	0	0	51.06	TRUE	0	0
2025-11-21	65	0	PUT	0	0	44.63	TRUE	0	0
2026-01-16	2.5	13	CALL	0	0	180.75	TRUE	0	0
2026-01-16	5	0	CALL	0	0	120.51	TRUE	0	0
2026-01-16	7.5	0	CALL	0	0	92.33	TRUE	0	0
2026-01-16	10	6.5	CALL	0	0	89.73	TRUE	0	0
2026-01-16	12.5	42.4	CALL	0	4	69.76	TRUE	0	0
2026-01-16	15	9	CALL	0	1	65.12	TRUE	0	0
2026-01-16	17.5	33.5	CALL	0	69	50.73	TRUE	0	0
2026-01-16	20	33.3	CALL	0	12	81.33	TRUE	0	0
2026-01-16	22.5	12.4	CALL	0	10	54.96	TRUE	0	0
2026-01-16	25	29	CALL	0	22	42.03	TRUE	0	0
2026-01-16	27.5	30.55	CALL	0	20	51.5	TRUE	0	0
2026-01-16	30	18.3	CALL	0	195	62.3	TRUE	0	0
2026-01-16	32.5	25.19	CALL	0	16	60.74	TRUE	0	0
2026-01-16	35	15.78	CALL	0	17	52.47	TRUE	0	0
2026-01-16	37.5	20.57	CALL	0	57	58.57	TRUE	0	0
2026-01-16	40	12.1	CALL	0	27	56.02	TRUE	0	0
2026-01-16	42.5	7.5	CALL	0	5	57.75	TRUE	0	0
2026-01-16	45	7.3	CALL	0	25	57.28	FALSE	0	0
2026-01-16	47.5	13.68	CALL	0	1	52.23	FALSE	0	0
2026-01-16	50	5.9	CALL	1	28	52.19	FALSE	5.9	0
2026-01-16	52.5	0	CALL	0	0	55.52	FALSE	0	0
2026-01-16	55	5.25	CALL	0	11	51.02	FALSE	0	0
2026-01-16	57.5	0	CALL	0	0	50.97	FALSE	0	0
2026-01-16	60	3.2	CALL	1	22	49.72	FALSE	3.2	0
2026-01-16	62.5	0	CALL	0	0	47.09	FALSE	0	0
2026-01-16	65	4	CALL	0	156	47.83	FALSE	0	0
2026-01-16	70	1.7	CALL	0	8	42.57	FALSE	0	0
2026-01-16	75	2.35	CALL	0	10	43.33	FALSE	0	0
2026-01-16	80	1	CALL	0	33	44.41	FALSE	0	0
2026-01-16	85	5.4	CALL	0	1	66.81	FALSE	0	0
2026-01-16	2.5	0	PUT	0	0	171.52	FALSE	0	0
2026-01-16	5	0.1	PUT	0	15	122.56	FALSE	0	0
2026-01-16	7.5	0	PUT	0	0	107.42	FALSE	0	0
2026-01-16	10	0	PUT	0	0	93.87	FALSE	0	0
2026-01-16	12.5	0.05	PUT	0	15	150.07	FALSE	0	0
2026-01-16	15	2.5	PUT	0	0	129.78	FALSE	0	0
2026-01-16	17.5	4.72	PUT	0	2	113.84	FALSE	0	0
2026-01-16	20	0.55	PUT	0	1656	82.76	FALSE	0	0
2026-01-16	22.5	8.14	PUT	0	1	87.74	FALSE	0	0
2026-01-16	25	0.6	PUT	0	65	52.05	FALSE	0	0
2026-01-16	27.5	0	PUT	0	0	50.79	FALSE	0	0
2026-01-16	30	2	PUT	0	23	51.01	FALSE	0	0
2026-01-16	32.5	0	PUT	0	0	51.17	FALSE	0	0
2026-01-16	35	3.2	PUT	0	24	49.58	FALSE	0	0
2026-01-16	37.5	4.05	PUT	0	2	52.35	FALSE	0	0
2026-01-16	40	5.31	PUT	0	200	52.07	FALSE	0	0
2026-01-16	42.5	6.5	PUT	0	38	48.15	FALSE	0	0
2026-01-16	45	8.15	PUT	0	4	48.94	TRUE	0	0
2026-01-16	47.5	10	PUT	0	1	50.85	TRUE	0	0
2026-01-16	50	10.5	PUT	0	14	50.7	TRUE	0	0
2026-01-16	52.5	0	PUT	0	0	51.88	TRUE	0	0
2026-01-16	55	0	PUT	0	0	47.19	TRUE	0	0
2026-01-16	57.5	0	PUT	0	0	45.83	TRUE	0	0
2026-01-16	60	0	PUT	0	0	42.95	TRUE	0	0
2026-01-16	62.5	0	PUT	0	0	38.99	TRUE	0	0
2026-01-16	65	0	PUT	0	0	44.34	TRUE	0	0
2026-01-16	70	24	PUT	0	2	58.92	TRUE	0	0
2026-01-16	75	0	PUT	0	0	66.76	TRUE	0	0
2026-01-16	80	36	PUT	0	0	75.82	TRUE	0	0
2026-01-16	85	0	PUT	0	0	79.42	TRUE	0	0

Latest AKRO Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	22	$8.07
Jun 13, 2022 7:59 PM EST	11	$8.07
Jun 13, 2022 7:59 PM EST	14	$8.06
Jun 13, 2022 7:59 PM EST	10	$8.07
Jun 13, 2022 7:59 PM EST	47	$8.07

Akero Therapeutics, Inc (AKRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-07-01	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-05-20	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1744659/000000000020004520/0000000000-20-004520-index.htm
2020-07-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-08	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1744659/000090514820000781/0000905148-20-000781-index.htm
2020-09-09	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1744659/000090514820001009/0000905148-20-001009-index.htm
2020-05-15	DRS	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1744659/000091205720000169/0000912057-20-000169-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-02-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-02-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-07-06	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1744659/000104746920003964/0001047469-20-003964-index.htm
2020-07-09	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1744659/000104746920004044/0001047469-20-004044-index.htm
2020-09-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1744659/000108514620002410/0001085146-20-002410-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-01-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920003240/0001104659-20-003240-index.htm
2020-01-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-02-13	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1744659/000110465920020276/0001104659-20-020276-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1744659/000110465920021077/0001104659-20-021077-index.htm
2020-02-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920025042/0001104659-20-025042-index.htm
2020-03-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-03-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920033680/0001104659-20-033680-index.htm
2020-03-16	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1744659/000110465920034183/0001104659-20-034183-index.htm
2020-03-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-31	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920040850/0001104659-20-040850-index.htm
2020-04-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-04-27	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1744659/000110465920051294/0001104659-20-051294-index.htm
2020-05-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920060866/0001104659-20-060866-index.htm
2020-05-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920066655/0001104659-20-066655-index.htm
2020-06-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920068978/0001104659-20-068978-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920069071/0001104659-20-069071-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920069072/0001104659-20-069072-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920069074/0001104659-20-069074-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920069075/0001104659-20-069075-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920069077/0001104659-20-069077-index.htm
2020-06-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920071713/0001104659-20-071713-index.htm
2020-06-11	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920072520/0001104659-20-072520-index.htm
2020-06-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920072521/0001104659-20-072521-index.htm
2020-06-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920074004/0001104659-20-074004-index.htm
2020-06-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920078983/0001104659-20-078983-index.htm
2020-07-01	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-07-06	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1744659/000110465920080872/0001104659-20-080872-index.htm
2020-07-06	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1744659/000110465920080873/0001104659-20-080873-index.htm
2020-07-07	8-K/A	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920081704/0001104659-20-081704-index.htm
2020-07-07	S-1MEF	Registration adding securities to prior Form S-1 registration [Rule 462(b)]	https://www.sec.gov/Archives/edgar/data/1744659/000110465920081820/0001104659-20-081820-index.htm
2020-07-10	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920082854/0001104659-20-082854-index.htm
2020-07-10	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920082855/0001104659-20-082855-index.htm
2020-07-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm
2020-07-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-08-07	RW	Registration Withdrawal Request	https://www.sec.gov/Archives/edgar/data/1744659/000110465920092022/0001104659-20-092022-index.htm
2020-08-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920093910/0001104659-20-093910-index.htm
2020-10-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1744659/000110465920115114/0001104659-20-115114-index.htm
2020-01-15	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1744659/000119312520008095/0001193125-20-008095-index.htm
2020-02-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1744659/000119312520028593/0001193125-20-028593-index.htm
2020-07-14	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1744659/000119312520192675/0001193125-20-192675-index.htm
2020-02-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000120919120008127/0001209191-20-008127-index.htm
2020-10-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1744659/000127417320000103/0001274173-20-000103-index.htm
2020-03-16	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1744659/000155837020002798/0001558370-20-002798-index.htm
2020-05-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1744659/000155837020006498/0001558370-20-006498-index.htm
2020-08-12	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1744659/000155837020010443/0001558370-20-010443-index.htm
2020-07-07	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1744659/999999999520001708/9999999995-20-001708-index.htm

Akero Therapeutics, Inc (AKRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc (AKRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 840%
Institutional Ownership: 9380%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2020-10-09	Kevin Bitterman	Director	Sell	13,000.00	28.93	376,090.00	11,780.00	https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-03-13	Jonathan Young	Chief Operating Officer	Buy	5,035.00	0.62	3,096.53	177,518.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-13	Jonathan Young	Chief Operating Officer	Buy	6,082.00	0.62	3,740.43	183,600.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-01-10	Jonathan Young	Chief Operating Officer	Buy	17,621.00	0.62	10,836.92	211,197.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-30	G. Walmsley Graham	Director	Buy	2,168.00	19.97	43,294.96	2,168.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-03-12	Timothy Rolph	Chief Scientific Officer	Buy	27,368.00	0.61	16,694.48	220,277.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-01-10	Jonathan Young	Chief Operating Officer	Buy	21,286.00	0.62	13,090.89	232,483.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-12	Timothy Rolph	Chief Scientific Officer	Buy	22,656.00	0.61	13,820.16	242,933.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-07-06	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	4,603.00	33.83	155,721.33	3,033,552.00	https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-02	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	3,800.00	33.63	127,805.40	3,038,155.00	https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-01	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	108,064.00	34.45	3,723,010.12	3,041,955.00	https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-01-21	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	17,849.00	22.39	399,639.11	3,092,698.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-21	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	8,091.00	21.78	176,221.98	3,110,547.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-17	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	11,103.00	20.09	223,059.27	3,118,638.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-16	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	22,489.00	19.72	443,483.08	3,129,741.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-03-06	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	1,800.00	23.79	42,830.82	3,150,019.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-03-05	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	8,500.00	23.53	200,010.95	3,151,819.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-15	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	7,511.00	19.73	148,192.03	3,152,230.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-14	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	12,307.00	20.00	246,140.00	3,159,741.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-04	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	35,650.00	23.81	848,765.90	3,160,319.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-13	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	83.00	20.84	1,729.72	3,172,048.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-13	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	11,593.00	20.16	233,714.88	3,172,131.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-10	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	19,343.00	20.10	388,794.30	3,183,724.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-03	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	6,401.00	23.00	147,198.68	3,195,969.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-02	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	10,297.00	23.06	237,459.12	3,202,370.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-09	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	16,527.00	20.21	334,010.67	3,203,067.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-28	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	5,100.00	21.30	108,652.44	3,212,667.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-08	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	22,368.00	19.80	442,886.40	3,219,594.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-10	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	7,836.00	27.08	212,168.32	3,225,861.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	1,781.00	22.54	40,143.74	3,227,767.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-26	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	2,523.00	22.44	56,615.36	3,229,548.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-25	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	1,600.00	23.67	37,876.00	3,232,071.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-12	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	6.00	27.14	162.84	3,233,671.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-11	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	2,184.00	27.05	59,068.03	3,233,677.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-06	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	6,102.00	27.03	164,954.76	3,233,697.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-05	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	28,608.00	25.99	743,547.67	3,239,799.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-07	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	14,162.00	20.05	283,948.10	3,241,962.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-06	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	42,323.00	19.93	843,497.39	3,256,124.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-02-04	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	53,731.00	25.65	1,378,178.66	3,268,407.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-06	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	6,101.00	18.32	111,770.32	3,298,447.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-06	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	4,968.00	17.68	87,834.24	3,304,548.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	100.00	20.27	2,027.00	3,309,516.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	3,100.00	19.18	59,458.00	3,309,616.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-13	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	494,000.00	20.23	9,993,620.00	3,322,138.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-01-08	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	15,677.00	19.86	311,354.63	3,816,138.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-07	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	31,000.00	20.17	625,149.10	3,831,815.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-06	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	42,221.00	19.64	829,380.88	3,862,815.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-03	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	12,498.00	19.30	241,213.90	3,905,036.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02	Global Strategic Fund II L.P. venBio	10% Share Holder	Sell	23,000.00	19.94	458,507.30	3,917,534.00	https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	1,000.00	22.17	22,170.00	3,996,859.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	3,900.00	21.20	82,680.00	3,997,859.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02	Versant Venture Capital VI, L.P.	10% Share Holder	Sell	10,952.00	19.89	217,835.28	4,001,759.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-07-10	Apple Tree Partners IV, L.P.	10% Share Holder	Buy	415,000.00	36.00	14,940,000.00	5,830,203.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-07-10	Seth Loring Harrison	Director	Buy	415,000.00	36.00	14,940,000.00	5,830,203.00	https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm

Akero Therapeutics, Inc

(NASDAQ:AKRO)